Northeast Financial Consultants’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$599K Hold
5,574
0.02% 188
2025
Q1
$562K Hold
5,574
0.02% 184
2024
Q4
$498K Hold
5,574
0.02% 192
2024
Q3
$467K Buy
5,574
+39
+0.7% +$3.07K 0.02% 199
2024
Q2
$426K Sell
5,535
-995
-15% -$72.8K 0.02% 202
2024
Q1
$447K Hold
6,530
0.02% 206
2023
Q4
$378K Hold
6,530
0.02% 212
2023
Q3
$345K Hold
6,530
0.02% 211
2023
Q2
$353K Hold
6,530
0.02% 215
2023
Q1
$327K Hold
6,530
0.02% 240
2022
Q4
$302K Hold
6,530
0.02% 241
2022
Q3
$253K Hold
6,530
0.02% 285
2022
Q2
$243K Hold
6,530
0.02% 284
2022
Q1
$289K Hold
6,530
0.02% 309
2021
Q4
$277K Hold
6,530
0.02% 294
2021
Q3
$283K Hold
6,530
0.02% 292
2021
Q2
$279K Hold
6,530
0.02% 296
2021
Q1
$252K Hold
6,530
0.02% 293
2020
Q4
$235K Hold
6,530
0.02% 289
2020
Q3
$250K Hold
6,530
0.02% 254
2020
Q2
$229K Buy
+6,530
New +$235K 0.02% 249
2019
Q4
Sell
-7,295
Closed -$297K 311
2019
Q3
$297K Hold
7,295
0.03% 246
2019
Q2
$314K Hold
7,295
0.03% 235
2019
Q1
$280K Buy
+7,295
New +$279K 0.03% 238

Other funds holding BSX

Northeast Financial Consultants's BSX Position: Q2 2025 in Review

Northeast Financial Consultants held its Boston Scientific (BSX) position steady in Q2 2025 at 5,574 shares worth $599K. The position accounts for 0.02% of the portfolio, ranked #188.

Northeast Financial Consultants first reported a position in BSX in Q1 2019 and has held it in 24 quarters since. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Northeast Financial Consultants held 5,574 shares of Boston Scientific worth $599K as of Q2 2025.
  • Northeast Financial Consultants left its Boston Scientific share count unchanged in Q2 2025.
  • Boston Scientific made up 0.02% of Northeast Financial Consultants's portfolio in Q2 2025, its #188 holding.
  • Northeast Financial Consultants first reported a position in Boston Scientific in Q1 2019 and has held it in 24 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.